SHMARQL

doxazosin

<http://www.wikidata.org/entity/Q419939>

group of stereoisomers
rdfs:label
"doxazosin"@en
skos:altLabel
"1-(4-amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin"@en
"1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin"@en
"UK-3327427"@en
schema:description
"group of stereoisomers"@en
schema:dateModified "2026-05-25T11:14:38+00:00"^^xsd:dateTime
schema:version 2497234802
wikibase:identifiers 62
wikibase:sitelinks 23
wikibase:statements 103
p:P10245 wd:statement/Q419939-824329b4-40ee-8d12-7cf3-10509572a28a
p:P10283 wd:statement/Q419939-77349104-BF01-4F85-A014-8551363A1518
p:P11089 wd:statement/Q419939-DC482806-D88E-4B74-99A3-3F56736D1760
p:P11143 wd:statement/Q419939-0803EE7E-ADD5-4E7D-975B-F5B3046AE40D
p:P11198 wd:statement/Q419939-41044416-8C80-4C27-A333-84ECDD7C69B9
p:P11199 wd:statement/Q419939-0F96321E-A9E8-4646-8539-C0E7EBEF9374
p:P117 wd:statement/Q419939-72fd104b-48fe-e136-6a87-4c3c50dc6be7
p:P129 wd:statement/Q419939-36A8446C-9C35-4877-8D1F-376185BC5534
wd:statement/Q419939-462097C6-1FF9-4BB1-8A6A-B266AA8D8A0B
wd:statement/Q419939-AFE57EBA-3569-4974-80E4-A3A5E93DB984
p:P1579 wd:statement/Q419939-E30A6D0B-FE34-4995-A90B-7A800708A4DE
p:P2057 wd:statement/Q419939-5790E2ED-4D84-4088-A744-43C9C7A560F0
p:P2067 wd:statement/Q419939-3B01B409-A5EF-448D-BB55-B2BD624A8E84
p:P2115 wd:statement/Q419939-085AEA8B-F2BC-40AB-8291-33397DA37B26
p:P2175 wd:statement/Q419939-544A63FA-A2FA-459C-8A64-B98EE3448AD3
wd:statement/Q419939-B8F508FD-9D3A-4578-A13B-32A645644AA9
wd:statement/Q419939-C6FED8A7-1AFF-4711-B214-6A7EE9622A6B
wd:statement/Q419939-E754B9E6-118F-49D0-B7CE-07B29634542C
wd:statement/Q419939-FF8E89E8-C06E-40D7-9AF6-7CF145869439
p:P2275 wd:statement/Q419939-4160C820-358D-41BD-B46A-8483F31397B5
p:P231 wd:statement/Q419939-D564CF46-43D6-46EA-AD7D-7E25EC3718C7
p:P232 wd:statement/Q419939-E9130337-675B-4C1E-8343-FA07E1B4EBB6
p:P233 wd:statement/Q419939-1F90412A-5C90-4042-875C-54441A09F4D9
p:P234 wd:statement/Q419939-67F2E256-F034-4C05-857B-8D42E9B8F3F9
p:P235 wd:statement/Q419939-3B5F52EC-53AB-4747-8EBE-B675E0470E76
p:P244 wd:statement/Q419939-c2671292-4cb2-0103-f452-fa3fcc07211e
p:P2566 wd:statement/Q419939-13572468-2468-1357-eca9-bdf024681357
p:P267 wd:statement/Q419939-A3F93337-3E76-4EEB-B0C0-14AD29860406
p:P274 wd:statement/Q419939-2B4F56EF-BDEC-4472-9D05-9DEC3213055E
p:P279 wd:statement/Q419939-93C6875E-5881-40B6-9452-C39B46CE08B4
p:P2868 wd:statement/Q419939-BA7D0C18-36C7-4F93-AB54-218F50114DBB
wd:statement/Q419939-D94C90D0-74A3-4AD7-AACD-AA12A4D4CAB1
wd:statement/Q419939-EDE40611-1631-46F9-9CD4-B478767DB6CC
p:P2877 wd:statement/Q419939-2ED53EDA-7FB2-46B6-9D9F-A3594DA2647A
p:P2892 wd:statement/Q419939-0F955D6B-D0B2-47A3-9C3E-DB3E1C3914C2
p:P31 wd:statement/Q419939-7da2af23-47b0-fc18-8f6b-b8da86b17967
p:P3117 wd:statement/Q419939-EBD2F704-C0EB-483C-B319-49BB14375037
p:P3345 wd:statement/Q419939-475F2F9B-AE3C-4ABA-AE92-5B8916A8EBE2
p:P373 wd:statement/Q419939-30A62380-90E3-4AB1-9317-943F2FC92CF3
p:P3780 wd:statement/Q419939-C5374D9C-6098-42CF-A228-C7F1E1B2BF1E
p:P4250 wd:statement/Q419939-5A6DACC6-164A-478C-AA2F-28BFD94DA84F
p:P486 wd:statement/Q419939-518B80A5-CD3E-4B9E-8322-63E896638B07
p:P4964 wd:statement/Q419939-06CE275A-50A4-4177-BD59-05F397FD8094
wd:statement/Q419939-1FB81F9B-A0AB-4188-8F17-A3BC0550578A
wd:statement/Q419939-3020B638-EE1C-473D-BACE-9F2A66AD099D
wd:statement/Q419939-37E90A51-073D-47DB-AB74-1A66E87AF185
wd:statement/Q419939-4C81CDB4-1CF6-4956-B0D4-D65EAD1D51FC
wd:statement/Q419939-5091CDD3-3CFE-4C42-93A0-0F0DFC61936B
wd:statement/Q419939-5DFB63ED-5C99-459C-8E28-A10D20796AAF
wd:statement/Q419939-737FF399-BD08-44F7-9D7B-A66BC6136DF5
wd:statement/Q419939-ACE98388-DE3C-4069-80F8-B8651103DE80
wd:statement/Q419939-AEF422C7-8034-48C5-ACA7-69FA48F0BBB4
wd:statement/Q419939-EC80B0FC-0CF4-4C1C-B2FD-CE96D1AF117F
p:P5076 wd:statement/Q419939-D287C765-B5FD-4634-8DE5-04D4EFF63166
p:P592 wd:statement/Q419939-86A30695-BCBC-477F-9B2A-2373DFCF2F35
p:P595 wd:statement/Q419939-7CD01747-D84D-43E4-B9F3-F3D535BB9CF6
p:P6366 wd:statement/Q419939-86D36C46-8BDC-45F1-8672-3A852253FAD7
p:P646 wd:statement/Q419939-170F9CBD-1AB5-406C-A5A1-E30B6BE5A5EE
p:P652 wd:statement/Q419939-E951053E-6A55-4F1D-844C-A76535E88A6F
p:P661 wd:statement/Q419939-8607A494-0D3A-4C06-AFFE-AF55B5BC8A04
p:P662 wd:statement/Q419939-57F08FAD-931D-4D44-ACC5-7592733F8EDB
p:P665 wd:statement/Q419939-1F9A7CA7-31AF-4E68-9815-AA30943D47E4
wd:statement/Q419939-466E81E2-E3EF-450C-9D2E-D77FF48AB2B1
p:P6689 wd:statement/Q419939-148C996D-ABC4-4577-9498-07A513538B0B
wd:statement/Q419939-2D826DE0-46C9-4C2D-9AA0-3E00987976F8
wd:statement/Q419939-3C302442-A085-478C-A867-4B2BEC49EDB5
wd:statement/Q419939-5F1CA640-DA3E-4119-8888-901E6A0EE83A
wd:statement/Q419939-663DD1B4-BF93-40DE-BAA5-47A46F5D3508
wd:statement/Q419939-776551AC-ECCE-444A-97CC-BA0EC5240179
wd:statement/Q419939-8C18CF1D-0F90-4EDF-BE10-2F138FDCC6E9
wd:statement/Q419939-A68AAB9F-A8A5-44DB-8E94-A8010E3B6654
wd:statement/Q419939-D9A2D9E7-73CA-45B0-B297-D67D298B4A47
wd:statement/Q419939-E98B06EF-E470-4E14-8F4C-73E9218BDBE8
wd:statement/Q419939-F0A4EF6F-D3AF-47F1-97E7-E2411F1FE2BD
wd:statement/Q419939-F52C0F47-58DB-4CE3-88EB-1D89A60B6D5A
p:P672 wd:statement/Q419939-d8ee53a8-4548-7788-fab0-82f44dc8737b
p:P683 wd:statement/Q419939-883DFA23-36F7-423C-88ED-45A1D7D55EA1
p:P715 wd:statement/Q419939-267E7723-8FB5-4370-8FB0-905C3CA6E8D5
p:P769 wd:statement/Q419939-016C2DAA-C537-4AF3-9DEE-9DA9563DE63F
wd:statement/Q419939-066D9F03-6375-465A-A524-0A02BEE33B5A
wd:statement/Q419939-108CD75A-DB87-4A6D-BE6E-CD460416D2C8
wd:statement/Q419939-14DFC69C-107B-429A-82CE-62C039C15C4A
wd:statement/Q419939-1D32B475-50B9-4962-861A-1D100AEBD899
wd:statement/Q419939-35470358-33C0-4B25-B677-33E8022C1009
wd:statement/Q419939-3920F899-7E70-457A-A478-83B12AAF383E
wd:statement/Q419939-46C566F1-0BD1-42A0-B4D9-531DC4332461
wd:statement/Q419939-4B545CBC-B896-4E92-9E98-E22D0BE1FDFF
wd:statement/Q419939-5483862A-9F1C-483C-BC15-ABEBE723D3DD
wd:statement/Q419939-6CAEE9E5-206C-45C8-A7CA-7ECAB15BC8F2
wd:statement/Q419939-6E6AA6AD-B996-47DF-8555-19405904DB5D
wd:statement/Q419939-70963CEE-4108-4335-B3CD-8D2A40073C35
wd:statement/Q419939-842F669B-A8B5-4F9E-B20D-86B4933DD1F5
wd:statement/Q419939-89E25E15-234E-407A-BC81-CE170D8A2910
wd:statement/Q419939-A0AB2F9A-0C72-4F89-8D4C-FD9424AE5A5E
wd:statement/Q419939-E09C421F-4B18-4737-BBEC-7F5CE383D588
wd:statement/Q419939-F5C5F08A-C0A6-48CE-B61E-CF299234E44E
wd:statement/Q419939-FC047E06-D174-4F78-BF94-8C9037CC0CA3
p:P7830 wd:statement/Q419939-C3E58901-B895-4FFB-A11B-815E4B93FB71
p:P8026 wd:statement/Q419939-0559A2C1-7898-4E60-8FC4-FAEE83319690
p:P8189 wd:statement/Q419939-b46b65f8-4767-08f5-22a5-2d3032a2c985
p:P8494 wd:statement/Q419939-13143121-4183-4CC8-BCE9-1DFEBD7630E1
p:P8814 wd:statement/Q419939-CED9ECA0-3DC3-47B1-8B6C-BE7758E7263B
p:P9272 wd:statement/Q419939-E8F46FA4-4033-466F-8956-FBBBD083D698
p:direct-normalized/P2115 <http://purl.bioontology.org/ontology/NDFRT/N0000147827>
p:direct-normalized/P244 <http://id.loc.gov/authorities/names/sh97002232>
p:direct-normalized/P486 <http://id.nlm.nih.gov/mesh/D017292>
p:direct-normalized/P592 <http://rdf.ebi.ac.uk/resource/chembl/molecule/CHEMBL707>
p:direct-normalized/P6366 <https://makg.org/entity/2777590997>
p:direct-normalized/P661 <http://rdf.chemspider.com/3045>
p:direct-normalized/P662 <http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3157>
p:direct-normalized/P665 <http://www.kegg.jp/entry/C06970>
<http://www.kegg.jp/entry/D07874>
p:direct-normalized/P672 <http://id.nlm.nih.gov/mesh/D03.633.100.786.750.200>
p:direct-normalized/P683 <http://purl.obolibrary.org/obo/CHEBI_4708>
p:direct-normalized/P8814 <http://wordnet-rdf.princeton.edu/rdf/id/03234359-n>
wdt:P10245 "a693045"
wdt:P10283 "C2777590997"
wdt:P11089 "210580"
wdt:P11143 "Doxazosin"
wdt:P11198 "954"
wdt:P11199 "PD003016"
wdt:P117 <http://commons.wikimedia.org/wiki/Special:FilePath/Doxazosin.svg>
wdt:P129 Adrenoceptor alpha 1A
Adrenoceptor alpha 1B
Adrenoceptor alpha 1D
wdt:P1579 "731849"
wdt:P2057 "HMDB0014728"
wdt:P2067 451.185569^^xsd:decimal
wdt:P2115 "N0000147827"
wdt:P2175 urinary retention
arterial hypertension
prostatic hypertrophy
wdt:P2275 "doxazosin"@en
wdt:P231 "74191-85-8"
wdt:P232 "616-059-6"
wdt:P233 "COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC"
wdt:P234 "InChI=1S/C23H25N5O5/c1-30-18-11-14-15(12-19(18)31-2)25-23(26-21(14)24)28-9-7-27(8-10-28)22(29)20-13-32-16-5-3-4-6-17(16)33-20/h3-6,11-12,20H,7-10,13H2,1-2H3,(H2,24,25,26)"
wdt:P235 "RUZYUOTYCVRMRZ-UHFFFAOYSA-N"
wdt:P244 "sh97002232"
wdt:P2566 "100.128.642"
wdt:P267 "C02CA04"
wdt:P274 "C₂₃H₂₅N₅O₅"
wdt:P279 medication
wdt:P2868 alpha blocker
adrenergic alpha-1 receptor antagonists
antihypertensive drug
wdt:P2877 "34111"
wdt:P2892 "C0114873"
wdt:P31 group of stereoisomers
wdt:P3117 "DTXSID7022964"
wdt:P3345 "49276"
wdt:P373 "Doxazosin"
wdt:P3780 Cardura
wdt:P4250 4.0^^xsd:decimal
wdt:P486 "D017292"
wdt:P4964 "splash10-0006-0079100000-06d36a9b7afe6cf0c6e9"
"splash10-000t-1091000000-cbd9b2106818ef5fd2ba"
"splash10-001i-1190000000-a1c84b0c3657d8000e35"
"splash10-001i-1390000000-e802cb93ca8d6934ee96"
"splash10-0a4i-0950000000-f649236044e4e2a5de38"
"splash10-0a4i-0970000000-5261f1bc60ceee4364de"
"splash10-0a4i-1900000000-88bca2ddf2930fa0c468"
"splash10-0a4i-1920000000-86655cc3bb892d757068"
"splash10-0kei-0981100000-a9ee3121ba6832366f8e"
"splash10-0udi-0002900000-3097c8a3403b52610918"
"splash10-0udi-0010900000-9601aa919c95799ec009"
wdt:P5076 "RD-04-02490"
wdt:P592 "CHEMBL707"
wdt:P595 "7170"
wdt:P6366 "2777590997"
wdt:P646 "/m/06p135"
wdt:P652 "NW1291F1W8"
wdt:P661 "3045"
wdt:P662 "3157"
wdt:P665 "C06970"
"D07874"
wdt:P6689 "MSBNK-Eawag-EQ329301"
"MSBNK-Eawag-EQ329302"
"MSBNK-Eawag-EQ329303"
"MSBNK-Eawag-EQ329304"
"MSBNK-Eawag-EQ329305"
"MSBNK-Eawag-EQ329306"
"MSBNK-Eawag-EQ329351"
"MSBNK-Eawag-EQ329352"
"MSBNK-Eawag-EQ329353"
"MSBNK-Eawag-EQ329354"
"MSBNK-Eawag-EQ329355"
"MSBNK-Eawag-EQ329356"
wdt:P672 "D03.633.100.786.750.200"
wdt:P683 "4708"
wdt:P715 "DB00590"
wdt:P769 sildenafil
avanafil
nifedipine
levobunolol
(RS)-metoprolol
atenolol
bisoprolol
carvedilol
sotalol
pindolol
nebivolol
acebutolol
celiprolol
propranolol
tadalafil
vardenafil
nadolol
betaxolol
labetalol
wdt:P7830 "Doxazosin"
wdt:P8026 LiverTox toxicity likelihood category E*
wdt:P8189 "987007556551805171"
wdt:P8494 "DTXCID402964"
wdt:P8814 "03234359-n"
wdt:P9272 "30747"
Download as:
TurtleJSON-LDRDF/XML
data from SPARQL profile: Wikidata